Status:
COMPLETED
Peripheral Oxytocin and Touch
Lead Sponsor:
University of California, San Diego
Conditions:
Healthy Adults
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Research shows that slow gentle skin stroking can activate special sensory nerves in the skin that elicit relaxing effects on the body and mind, similar to the effects of the hormone oxytocin. Studies...
Eligibility Criteria
Inclusion
- Between the ages of 18 and 65 years old
- Fluent in English
- Healthy
Exclusion
- Sensory or motor nerve deficit
- Acute or chronic pain
- Major medical conditions such as kidney, liver, cardiovascular (hypertension, preexisting cardiac arrhythmia), autonomic, pulmonary, or neurological problems (e.g., seizure disorder) or a chronic systemic disease (e.g., diabetes).
- Any disease, diagnosis, or condition (medical or surgical) that, in the opinion of the Principal Investigator, would place the subject at increased risk (active gynecologic disease in which increased tone would be detrimental e.g., uterine fibroids with ongoing bleeding), compromise the subject's compliance with study procedures, or compromise the quality of the data
- Unstable psychiatric conditions
- Needle phobia or history of fainting
- Current use of opiate medication(s)
- Hypersensitivity, allergy, or significant reaction to any ingredient of Pitocin®
- Currently pregnant or pregnant within the last two years
- Currently nursing or lactating
- Current or history of ventricular tachycardia, atrial fibrillation or prolonged QT interval
- Past or current history of hyponatremia or at risk for hyponatremia
- Current use of thiazide diuretics, loop diuretics, combination diuretics, lithium, carbamazepine, enalapril, Ramipril, celecoxib, temazepam, gliclazide, glimepiride, glibenclamide, glipizide, omeprazole, pantoprazole, desmopressin, selective serotonin reuptake inhibitors, monoamine oxidase inhibitora, or the recreational drug ecstasy
- Latex allergy
Key Trial Info
Start Date :
April 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05326776
Start Date
April 5 2023
End Date
August 3 2023
Last Update
December 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTRI
La Jolla, California, United States, 92115